News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Purdue Pharma L.P. Presents Data From Research Studies At American Pain Society 33rd Annual Scientific Meeting


4/29/2014 9:47:51 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

STAMFORD, Conn., April 29, 2014 /PRNewswire/ -- Purdue Pharma L.P. will present results from a number of research studies at the American Pain Society (APS) 33rd Annual Scientific Meeting, April 30-May 3, 2014, in Tampa, Fla.

Following is a schedule of select poster presentations:


Title

Authors

Date / Time

A Single-Center, Randomized, Double-Blind

Crossover Study to Evaluate the Abuse

Potential, Pharmacokinetics, and Safety of

Milled and Intranasally Administered Extended-

Release Hydrocodone in Recreational Opioid

Users

Harris S, Colucci S, Perrino P, KapilR, Geoffroy P, HopyanT, Levy-Cooperman N

Thursday, May 1

9:30 AM11:00 AM

A Single-Center, Randomized, Double-Blind,

Crossover Study to Evaluate the Abuse

Potential, Pharmacokinetics, and Safety of Oral

Milled and Intact Extended-Release

Hydrocodone (HYD) Tablets in Recreational

Opioid Users

Harris S, Colucci S, Perrino P, KapilR, Geoffroy P, HopyanT, Levy-Cooperman N

Friday, May 2

8:45 AM-10:15 AM

Long-term Safety and Effectiveness of Once-

daily, Single-entity, Abuse-deterrent

Hydrocodone in Chronic Nonmalignant and

Nonneuropathic Pain: Results of a Long-term

Open-label Study

WenW, TaberL, LynchSY, MuneraC, Ripa SR

Thursday, May 1

9:30 AM11:00 AM

In Vitro Assessment of the Effects of Alcohol on

the Release Rate of Hydrocodone Bitartrate

from a Once-daily, Single-Entity, Hydrocodone

Bitartrate Formulation

Giordano J, Huang H, Kianto J

Friday, May 2

8:45 AM-10:15 AM

Comparison of the Risk of Opioid Overdose

among Patients Prescribed Immediate-Release

and Extended-Release Opioid Analgesics

Coplan P, DeVeaugh-Geiss A, Kadakia A

Thursday, May 1

9:30 AM11:00 AM

Abuse-deterrent Opioid Analgesic

Formulations: Technology, Evaluation, and

Labeling

Haddox D

Friday, May 2, 2014

8:45 AM - 10:15 AM

Impact of an opioid reformulation with abuse-

deterrent properties on doctor-shopping

Chilcoat H, Coplan PM, Sessler NE, Schultz Y, Yuan Y

Friday, May 2, 2014

8:45 AM - 10:15 AM

Epidemiology of Conditions Associated with

Pain and the Use of Analgesic and Non-

Analgesic Treatments in Pediatrics

Wallace L, Baldridge S, Matsuno R

Thursday, May 1

9:30 AM 11:00 AM

Neonatal Abstinence Syndrome in

Commercially-insured and Medicaid Patients:

Differences in Patient and Maternal

Characteristics and Outpatient Treatment

Patterns

Wallace L, Harding B, Matsuno RK

Thursday, May 1,

9:30 AM 11:00 AM


About Purdue Pharma L.P.

Purdue Pharma L.P. and its associated U.S. companies are privately-held pharmaceutical companies known for pioneering research on persistent pain. Headquartered in Stamford, CT, Purdue is engaged in the research, development, production, and distribution of both prescription and over-the-counter medicines and hospital products. Additional information about Purdue can be found at www.purduepharma.com.



Contact:


James Heins

Jennifer Soares

Senior Director, Public Affairs

Senior Manager, Corporate Affairs & Communications

office: 203-588-8069

office: 203-588-7623

mobile: 203-856-2121

mobile: 203-609-1746

Email: james.heins@pharma.com

email: jennifer.soares@pharma.com

SOURCE Purdue Pharma L.P.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES